John R Subjeck Selected Research

John R Subjeck Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 01/2002
9	Melanoma (Melanoma, Malignant) 01/2022 - 06/2003
5	Neoplasm Metastasis (Metastasis) 01/2014 - 06/2003
4	Atherosclerosis 01/2015 - 05/2007
4	Infections 04/2012 - 06/2006
3	Carcinoma (Carcinomatosis) 04/2006 - 08/2002
2	Experimental Melanoma 04/2013 - 09/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2010 - 07/2007
1	Hepatitis 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 11/2012
1	Alzheimer Disease (Alzheimer's Disease) 04/2012
1	Shock 04/2012
1	Pathologic Processes 04/2012
1	Vesicular Stomatitis 04/2011
1	Virus Diseases (Viral Diseases) 04/2011
1	Hypoxia (Hypoxemia) 12/2008
1	Communicable Diseases (Infectious Diseases) 06/2006
1	Fever (Fevers) 06/2006
1	Breast Neoplasms (Breast Cancer) 04/2006
1	Necrosis 01/2005
1	Hyperthermia 01/2002

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 01/2022 - 01/2002
15	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018 - 01/2002
13	AntigensIBA 01/2020 - 03/2002
12	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2002
9	glucose-regulated protein 170IBA 01/2018 - 06/2003
7	Scavenger Receptors (Scavenger Receptor)IBA 01/2015 - 05/2007
5	Neoplasm Antigens (Tumor Antigens)IBA 01/2014 - 03/2006
4	Molecular Chaperones (Chaperone, Molecular)IBA 01/2018 - 01/2004
3	CytokinesIBA 11/2012 - 01/2005
3	Peptides (Polypeptides)IBA 07/2007 - 01/2002
3	Cancer VaccinesIBA 08/2006 - 08/2002
2	FlagellinIBA 01/2021 - 04/2013
2	Carbonic Anhydrase IXIBA 12/2008 - 07/2007
2	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2005 - 10/2003
1	Pattern Recognition ReceptorsIBA 01/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2014
1	InterleukinsIBA 04/2013
1	Concanavalin AIBA 01/2013
1	CPG-oligonucleotideIBA 04/2012
1	Antiviral Agents (Antivirals)IBA 04/2011
1	Toll-Like Receptor 3IBA 04/2011
1	Protein Subunit VaccinesIBA 06/2010
1	EpitopesIBA 06/2010
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2009
1	Interleukin-2 (IL2)IBA 12/2008
1	Naphazoline (All Clear)FDA LinkGeneric 12/2008
1	HSP110 Heat-Shock ProteinsIBA 07/2007
1	LipopolysaccharidesIBA 05/2007
1	Lipoproteins (Lipoprotein)IBA 05/2007
1	Vaccine AdjuvantsIBA 06/2006
1	Chemokine CCL5IBA 04/2006
1	Cell Surface ReceptorsIBA 01/2005
1	Immunoglobulin G (IgG)IBA 10/2003
1	Therapeutic UsesIBA 06/2003
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2002
1	Complementary DNA (cDNA)IBA 08/2002
1	glucose-regulated proteinsIBA 01/2002

Therapy/Procedure

12	Immunotherapy 01/2021 - 01/2002
4	Therapeutics 01/2014 - 12/2008
2	Radiotherapy 01/2020 - 11/2012